This is the second guest column by Rachel Andrews of Gloucestershire, U.K., a Breast Cancer News reader who developed severe lymphedema as a result of her cancer and underwent a microsurgery procedure intended to correct ... Read more
Results from an international clinical trial led by a University of Pittsburgh Cancer Institute (UPCI) professor revealed that surgery to remove the primary tumor in women diagnosed with stage 4 breast ... Read more
Nektar Therapeutics and Daiichi Sankyo Europe have announced they signed an agreement for Nektar’s investigational drug therapy Onzeald (etirinotecan pegol) — formerly NKTR-102 – just after the completion of a ... Read more
University of California researchers have published findings in the journal Cell Chemical Biology that may lead to the development of novel breast cancer treatments that successfully target and eliminate triple-negative breast tumors (TNBT). ... Read more
Takeda Pharmaceutical Company and Mersana Therapeutics have announced a new alliance that grants Takeda rights over XMT-1522, the lead product candidate of Mersana, outside the U.S. and Canada. The agreement also ... Read more
During its annual meeting, the American Association for Cancer Research (AACR) announced that a scientific report describing a drug targeting the unprecedented genomic sequencing of 14 metastatic triple-negative breast cancers was the ... Read more
Researchers at University of Tsukuba and The Japanese Foundation for Cancer Research recently revealed that older breast cancer patients are at higher risk of developing bronchiolitis obliterans organizing pneumonia (BOOP) due to radiation therapy used as ... Read more
Currently, there are no approved therapies to target triple-negative breast cancer, however, novel chemotherapy strategies can reduce the size of tumors so that less breast tissue needs to be removed ... Read more
A team of scientists from The University of Manchester in the United Kingdom, working in collaboration with Evgen Pharma, have developed a new drug combination that may overcome relapse and treatment ... Read more
Researchers from The University of Texas at El Paso (UTEP) are developing technology to predict if and when breast cancer will appear. “We’re creating a breast cancer risk analysis system,” said electrical ... Read more
// Fill in your MailChimp popup settings below.
// These can be found in the original popup script from MailChimp.
var mailchimpConfig = {
baseUrl: 'mc.us5.list-manage.com',
uuid: '52c64784d386bd00ea57ee792',
lid: 'ea3614260e'
};
// No edits below this line are required
var chimpPopupLoader = document.createElement("script");
chimpPopupLoader.src = '//s3.amazonaws.com/downloads.mailchimp.com/js/signup-forms/popup/embed.js';
chimpPopupLoader.setAttribute('data-dojo-config', 'usePlainJson: true, isDebug: false');
var chimpPopup = document.createElement("script");
chimpPopup.appendChild(document.createTextNode('require(["mojo/signup-forms/Loader"], function (L) { L.start({"baseUrl": "' + mailchimpConfig.baseUrl + '", "uuid": "' + mailchimpConfig.uuid + '", "lid": "' + mailchimpConfig.lid + '"})});'));
jQuery(function ($) {
//document.body.appendChild(chimpPopupLoader);
//$(window).load(function () {
// document.body.appendChild(chimpPopup);
});
});
